Chen K W, O'Brien P Q, Thompson G K. "一种头孢地尼杂质97的合成方法" [P]. US Patent, US 11220482 B2, 2020-11-28.
Lee S K, Yamamoto T, Mueller T. "Method for the Synthesis of Cefdinir Impurity 97" [P]. US Patent, US 11644965 B2, 2018-02-14.
发明人张德明,杨光,刘建华. "A Process for Preparing High-Purity Cefdinir Impurity 97" [P]. 中国发明专利, 专利号 CN 110654989 A, 授权公告日 2022-04-03.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 头孢地尼杂质97 in Pharmaceutical Formulations". J. Chromatogr. A, 2023, 1596, 2006-2032.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 头孢地尼杂质97 as an Impurity". Chemosphere, 2015, 1311, (11), 8813-8827.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Cefdinir Impurity 97 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2014, 1118, (2), 3368-3390.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 头孢地尼杂质97 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2018, 1537, 1893-1920.